---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-23-010553"
form_type: "8-K"
ticker: null
cik: "0001029125"
company_name: "Panbela Therapeutics, Inc."
filed_at: "2023-04-18T23:59:59+00:00"
generated_at: "2026-06-17T00:22:56.622192+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Panbela receives Nasdaq bid price deficiency notice; issues preferred stock with 100M votes to Chairman

## Summary
- Received Nasdaq notice: common stock bid price below $1.00 for 30 consecutive days; 180-day cure period until Oct 11, 2023.
- Issued 1 share of Series A Preferred Stock to Chairman Michael T. Cullen for $10; share carries 100M votes solely on reverse stock split proposals.
- Amended bylaws to reduce stockholder quorum from majority to one-third of voting power.
- Preferred stock is not convertible, has no dividend or liquidation rights; redeemable at $10 upon board order or stockholder approval of reverse split.
- Company warns no assurance of regaining compliance; may face delisting if not cured.

## SEC filing metadata
- accession: 0001437749-23-010553
- form_type: 8-K
- cik: 0001029125
- company_name: Panbela Therapeutics, Inc.
- filed_at: 2023-04-18T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 1.01, 5.03, 3.01, 3.02, 3.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1029125/000143774923010553/0001437749-23-010553-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1029125/000143774923010553/pbla20230417_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-23-010553
- JSON: https://secwatch.observer/filing/0001437749-23-010553.json
- Plain text: https://secwatch.observer/filing/0001437749-23-010553.txt

## Key facts
- Governance Changes
  Panbela Therapeutics, Inc.: Reduced stockholder meeting quorum requirement from majority to one-third of voting power (effective 2023-04-14).
  - Change: bylaw amendment
  - Effective: 2023-04-14
  source text: On April 14, 2023, the Board of Directors of the Company amended and restated the Company’s Bylaws (as so amended and restated, the “Bylaws”) to reduce the quorum requirement at meetings of the Company’s stockholders from a majority of the voting power of the shares of stock of the Company issued and outstanding and entitled to vote, present in person or represented by proxy, to one-third of the voting power of the shares of stock of the Company issued and outstanding and entitled to vote, present in person or represented by proxy, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1029125/000143774923010553/0001437749-23-010553-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.